Alnylam Pharmaceuticals

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALNY and other ETFs, options, and stocks.

About ALNY

Alnylam Pharmaceuticals, Inc. is a global commercial-stage biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. Its products include ONPATTRO, GIVLAARI, and OXLUMO.

CEO

Yvonne L. Greenstreet

CEOYvonne L. Greenstreet

Employees

2,002

Employees2,002

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2002

Founded2002

Employees

2,002

Employees2,002

ALNY Key Statistics

Market cap

21.62B

Market cap21.62B

Price-Earnings ratio

-20.05

Price-Earnings ratio-20.05

Dividend yield

—

Dividend yield—

Average volume

593.58K

Average volume593.58K

High today

$179.77

High today$179.77

Low today

$172.51

Low today$172.51

Open price

$178.17

Open price$178.17

Volume

558.01K

Volume558.01K

52 Week high

$242.97

52 Week high$242.97

52 Week low

$168.65

52 Week low$168.65

ALNY News

Benzinga 2d

Antisense Therapy Market | Alnylam Pharmaceuticals, Arbutus ... - Benzinga

The global antisense therapy market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the antisense...

Benzinga 4d

Analyst Expectations for Alnylam Pharmaceuticals's Future - Alnylam Pharmaceuticals - Benzinga

Over the past 3 months, 20 analysts have published their opinion on Alnylam Pharmaceuticals ALNY stock. These analysts are typically employed by large Wall Stre...

Analyst ratings

79%

of 28 ratings

Buy

78.6%

Hold

21.4%

Sell

ALNY Earnings

-$2.03

-$1.35

-$0.68

$0.00

Q1 FY22

Q2 FY22

Q3 FY22

Q4 FY22

Q1 FY23

Q2 FY23

Q3 FY23

Estimated

-$1.44 per share

Estimated-$1.44 per share

Actual

Expected Nov 2, Pre-Market

ActualExpected Nov 2, Pre-Market